Molecular Neuropharmacology of Nociceptive Transmission and Opioid Receptors

DOI DOI Web Site Web Site PubMed 37 References Open Access

Bibliographic Information

Other Title
  • 痛覚情報伝達機構及びオピオイド受容体に関する神経薬学的研究
  • ツウカク ジョウホウ デンタツ キコウ オヨビ オピオイド ジュヨウタイ ニ カンスル シンケイ ヤクガクテキ ケンキュウ

Search this article

Description

This review summarizes our studies using pharmacological, neurochemical and molecular biological methods on the nociception in the CNS and opioid receptors (OPRs). We designed an in vitro fluorometric on-line monitoring system including an immobilized glutamate dehydrogenase column, and for the first time actually demonstrated that capsaicin induced the release of glutamate from rat dorsal horn slices containing the terminal area of primary afferents, in concentration-dependent, extracellular Ca2+-dependent and tetrodotoxin-resistant manners. Further, such a release was shown to be inhibited through μ- and δ-opioid receptors and α2-adrenoceptors. On the other hand, we found that intracerebroventricular injections of interleukin (IL)-1β in rats produced biphasic effects on the mechanical nociception in rats (hyperalgesia in lower concentrations but analgesia in higher ones) and that similar injections of cytokine-induced neutrophil chemoattractant-1 (CINC-1) facilitated mechanical nociception in rats. The above described facts suggest that glutamate and some sorts of cytokines (IL-1β and CINC-1) contribute to nociception at least from the primary afferents to the spinal dorsal horn neurons and in higher brain, respectively. We have cloned rat κ- and μ-opioid receptors. Using cloned cDNA for OPRs, we demonstrated (1) the distribution of mRNAs for OPRs in the rat central nervous system, (2) coexistence of each type of mRNA for μ-, δ- and κ-OPRs and pre-protachykinin A mRNA in the dorsal root ganglion neurons, (3) an increased expression of μ- and κ-OPR mRNAs in the I-II layers of rat lumbar dorsal horn with an adjuvant arthritis in the hind limb, (4) the inhibitions of N- and Q-types of Ca2+ channels by μ-and κ-OPR agonists and (5) cross-desensitization of the inhibition through a common intracellular phosphorylation-independent mechanism, (6) pharmacological characterization of "antagonist analgesics" as partial agonists at every type of OPRs, and (7) the key-structure(s) of OPRs for discriminative binding of DAMGO to μ-OPR.

Journal

  • YAKUGAKU ZASSHI

    YAKUGAKU ZASSHI 120 (12), 1291-1307, 2000

    The Pharmaceutical Society of Japan

References(37)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top